Neuropace Inc
General ticker "NPCE" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $324.1M
Neuropace Inc does not follow the US Stock Market performance with the rate: -18.5%.
Estimated limits based on current volatility of 5.2%: low 10.72$, high 11.89$
Factors to consider:
- Current price 299.4% above estimated high
- Earnings for 18 months up through Q2 (+1 year) are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [1.06$, 3.31$]
- 2023-12-31 to 2024-12-30 estimated range: [0.98$, 2.86$]
Short-term NPCE quotes
Long-term NPCE plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $45.18MM | $45.52MM | $65.42MM |
| Operating Expenses | $68.92MM | $86.31MM | $92.59MM |
| Operating Income | $-23.74MM | $-40.79MM | $-27.17MM |
| Non-Operating Income | $-12.34MM | $-6.29MM | $-5.78MM |
| Interest Expense | $7.41MM | $7.53MM | $8.52MM |
| R&D Expense | $18.21MM | $21.95MM | $20.78MM |
| Income(Loss) | $-36.08MM | $-47.08MM | $-32.96MM |
| Profit(Loss) | $-36.08MM | $-47.08MM | $-32.96MM |
| Stockholders Equity | $73.50MM | $34.78MM | $20.65MM |
| Inventory | $7.82MM | $9.71MM | $11.21MM |
| Assets | $133.56MM | $114.11MM | $107.65MM |
| Operating Cash Flow | $-24.58MM | $-36.87MM | $-19.70MM |
| Capital expenditure | $0.38MM | $0.60MM | $0.17MM |
| Investing Cash Flow | $-85.40MM | $23.80MM | $23.03MM |
| Financing Cash Flow | $102.53MM | $0.49MM | $8.13MM |
| Earnings Per Share* | $-1.56 | $-2.17 | $-1.27 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.